AGH
Pharmaceuticals, Biotechnology & Life Sciences
Althea Group Holdings
- Short interest
- 0.00%
- −0.98 pp 30d
- as of 6 Nov 2024
- Reported shorts
- 20K
- Shares on issue
- 405.332M
Althea Group Holdings (AGH) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for AGH (last checked 14 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Annual Report to shareholdersAnnual Report30 Sep 2026via asx_announcements
- Preliminary Final ReportAnnual Results31 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report29 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report29 Apr 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results27 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report2 Feb 2026via asx_announcements
- Continuous Disclosure PolicyFinancial Report31 Dec 2025via smart_crawler
- Whistleblower PolicyFinancial Report31 Dec 2025via smart_crawler
- Diversity PolicyFinancial Report31 Dec 2025via smart_crawler
- ProspectusFinancial Report31 Dec 2025via smart_crawler
Showing 10 of 32 reports